<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33931719</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.</ArticleTitle><Pagination><StartPage>509</StartPage><MedlinePgn>509</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">509</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-021-02034-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease characterized by death of motor neurons. The etiology and pathogenesis remains elusive despite decades of intensive research. Herein, we report that dysregulated metabolism plays a central role in the SOD1 G93A mouse model mimicking ALS. Specifically, we report that the activity of carnitine palmitoyl transferase 1 (CPT1) lipid metabolism is associated with disease progression. Downregulation of CPT1 activity by pharmacological and genetic methods results in amelioration of disease symptoms, inflammation, oxidative stress and mitochondrial function, whereas upregulation by high-fat diet or corticosterone results in a more aggressive disease progression. Finally, we show that downregulating CPT1 shifts the gut microbiota communities towards a protective phenotype in SOD1 G93A mice. These findings reveal that metabolism, and specifically CPT1 lipid metabolism plays a central role in the SOD1 G93A mouse model and shows that CPT1 might be a therapeutic target in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trabjerg</LastName><ForeName>Michael Sloth</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-7765-1966</Identifier><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Dennis Christian</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huntjens</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oklinski</LastName><ForeName>Kirsten Egelund</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolther</LastName><ForeName>Luise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hald</LastName><ForeName>Jonas Laug&#xe5;rd</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baisgaard</LastName><ForeName>Amalie Elton</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;rk</LastName><ForeName>Kasper</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warming</LastName><ForeName>Nikolaj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullab</LastName><ForeName>Ulla Bismark</ForeName><Initials>UB</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroese</LastName><ForeName>Lona John</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Mouse Clinic for Cancer and Aging Research, Transgenic Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pritchard</LastName><ForeName>Colin Eliot Jason</ForeName><Initials>CEJ</Initials><AffiliationInfo><Affiliation>Mouse Clinic for Cancer and Aging Research, Transgenic Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huijbers</LastName><ForeName>Ivo Johan</ForeName><Initials>IJ</Initials><Identifier Source="ORCID">0000-0002-7954-8604</Identifier><AffiliationInfo><Affiliation>Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieland</LastName><ForeName>John Dirk Vestergaard</ForeName><Initials>JDV</Initials><Identifier Source="ORCID">0000-0001-7423-0122</Identifier><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Aalborg, Denmark. Jdn@hst.aau.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004852">Epoxy Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.21</RegistryNumber><NameOfSubstance UI="D002334">Carnitine O-Palmitoyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>MSB3DD2XP6</RegistryNumber><NameOfSubstance UI="C054207">etomoxir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002334" MajorTopicYN="N">Carnitine O-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004852" MajorTopicYN="N">Epoxy Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33931719</ArticleId><ArticleId IdType="pmc">PMC8087699</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-02034-z</ArticleId><ArticleId IdType="pii">10.1038/s42003-021-02034-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu / Zn superoxide dismutase gene are associated. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt F, Hussain G, Dupuis L, Loeffler J-P, Henriques A. A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front. Cell. Neurosci. 2014;8:25. doi: 10.3389/fncel.2014.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00025</ArticleId><ArticleId IdType="pmc">PMC3929843</ArticleId><ArticleId IdType="pubmed">24600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, de Aguilar J-LG, Loeffler J-P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc. Natl Acad. Sci. USA. 2013;110:10812&#x2013;10817. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Virmani, A. et al. Neuronal carnitine palmitoyl transferase1c in the central nervous system: current visions and perspectives. J. Alzheimer&#x2019;s Dis. Park. 3, 1&#x2013;9 (2013).</Citation></Reference><Reference><Citation>van der Windt GJW, et al. Mitochondrial respiratory capacity is a critical regulator of CD8 + T cell memory development. Immunity. 2012;36:68&#x2013;78. doi: 10.1016/j.immuni.2011.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.12.007</ArticleId><ArticleId IdType="pmc">PMC3269311</ArticleId><ArticleId IdType="pubmed">22206904</ArticleId></ArticleIdList></Reference><Reference><Citation>Shriver, L. P. &amp; Manchester, M. Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci. Rep. 1, 79 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216566</ArticleId><ArticleId IdType="pubmed">22355598</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyzos AA, et al. Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in huntington mice. Cell Metab. 2019;29:1258&#x2013;1273.e11. doi: 10.1016/j.cmet.2019.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.03.004</ArticleId><ArticleId IdType="pmc">PMC6583797</ArticleId><ArticleId IdType="pubmed">30930170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front. Mol. Neurosci. 2018;11:1&#x2013;25. doi: 10.3389/fnmol.2018.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787076</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 2007;48:1571&#x2013;1580. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharaoh G, et al. Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front. Neurosci. 2019;13:1&#x2013;19. doi: 10.3389/fnins.2019.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00487</ArticleId><ArticleId IdType="pmc">PMC6554287</ArticleId><ArticleId IdType="pubmed">31213966</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, et al. Metabolic changes associated with muscle expression of SOD1G93A. Front. Physiol. 2018;9:1&#x2013;9. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rkholt AS, et al. CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis. Sci. Rep. 2019;9:1&#x2013;11. doi: 10.1038/s41598-019-49868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49868-6</ArticleId><ArticleId IdType="pmc">PMC6746708</ArticleId><ArticleId IdType="pubmed">31527712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, et al. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska Natives. JAMA Neurol. 2013;70:476&#x2013;480. doi: 10.1001/jamaneurol.2013.929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.929</ArticleId><ArticleId IdType="pubmed">23440294</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rkholt AS, et al. Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-&#x3b2;. Sci. Rep. 2018;8:1&#x2013;11. doi: 10.1038/s41598-018-25391-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25391-y</ArticleId><ArticleId IdType="pmc">PMC5935685</ArticleId><ArticleId IdType="pubmed">29728570</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rkholt AS, et al. Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents. PLoS ONE. 2020;15:e0234493. doi: 10.1371/journal.pone.0234493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234493</ArticleId><ArticleId IdType="pmc">PMC7286491</ArticleId><ArticleId IdType="pubmed">32520953</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg MS, et al. Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models. Sci. Rep. 2020;10:1&#x2013;19. doi: 10.1038/s41598-020-72638-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72638-8</ArticleId><ArticleId IdType="pmc">PMC7519132</ArticleId><ArticleId IdType="pubmed">32973137</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmers S, et al. Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proc. Natl Acad. Sci. USA. 2012;109:11711&#x2013;11716. doi: 10.1073/pnas.1206868109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206868109</ArticleId><ArticleId IdType="pmc">PMC3406830</ArticleId><ArticleId IdType="pubmed">22753483</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandanmagsar B, et al. Impaired mitochondrial fat oxidation induces FGF21 in muscle. Cell Rep. 2016;15:1686&#x2013;1699. doi: 10.1016/j.celrep.2016.04.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.057</ArticleId><ArticleId IdType="pmc">PMC4880522</ArticleId><ArticleId IdType="pubmed">27184848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreilaus F, et al. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes. Genes Brain Behav. 2020;19:1&#x2013;14. doi: 10.1111/gbb.12604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12604</ArticleId><ArticleId IdType="pubmed">31412164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, et al. 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8:11855&#x2013;11867. doi: 10.18632/oncotarget.14416.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14416</ArticleId><ArticleId IdType="pmc">PMC5355309</ArticleId><ArticleId IdType="pubmed">28060747</ArticleId></ArticleIdList></Reference><Reference><Citation>Luh LM, Das I, Bertolotti A. qMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice. Nat. Protoc. 2017;12:1451&#x2013;1457. doi: 10.1038/nprot.2017.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.062</ArticleId><ArticleId IdType="pmc">PMC5568708</ArticleId><ArticleId IdType="pubmed">28686587</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hong SY, Kliot M, M&#xf6;ller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport. 2003;14:1051&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 2011;1394:90&#x2013;104. doi: 10.1016/j.brainres.2011.02.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.02.060</ArticleId><ArticleId IdType="pubmed">21354109</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming, S. M., Ekhator, O. R. &amp; Ghisays, V. Assessment of sensorimotor function in mouse models of Parkinson&#x2019;s disease. J. Vis. Exp. 1&#x2013;7 10.3791/50303 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727502</ArticleId><ArticleId IdType="pubmed">23851663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Halicek MT, Mitchell CS. Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis. J. Neuromuscul. Dis. 2015;2:137&#x2013;150. doi: 10.3233/JND-140068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140068</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: A Mendelian randomization study. Hum. Mol. Genet. 2019;28:688&#x2013;697. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yazdani S, Piehl F, Magnusson PKE, Fang F. Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;67:202.e1&#x2013;202.e6. doi: 10.1016/j.neurobiolaging.2018.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.022</ArticleId><ArticleId IdType="pubmed">29685649</ArticleId></ArticleIdList></Reference><Reference><Citation>Che&#x142;stowska, B., Bara&#x144;czyk-Ku&#x17a;ma, A. &amp; Ku&#x17a;ma-Kozakiewicz, M. Dyslipidemia in patients with amyotrophic lateral sclerosis&#x2014;a case control retrospective study. Amyotroph. Lateral Scler. Front. Degener. 1&#x2013;11 10.1080/21678421.2020.1832119 (2020).</Citation></Reference><Reference><Citation>Rafiq MK, Lee E, Bradburn M, Mcdermott CJ, Shaw PJ. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial. Amyotroph. Lateral Scler. Front. Degener. 2015;16:478&#x2013;484. doi: 10.3109/21678421.2015.1062517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062517</ArticleId><ArticleId IdType="pubmed">26161993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2019;20:53&#x2013;60. doi: 10.1080/21678421.2018.1550516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550516</ArticleId><ArticleId IdType="pubmed">30784318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin W, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J. Lipid Res. 2012;53:51&#x2013;65. doi: 10.1194/jlr.M019927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M019927</ArticleId><ArticleId IdType="pmc">PMC3243481</ArticleId><ArticleId IdType="pubmed">22021650</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler T, Schilcher I, Flunkert S, Hutter-Paier B. Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value. Front. Neurosci. 2020;14:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300175</ArticleId><ArticleId IdType="pubmed">32595447</ArticleId></ArticleIdList></Reference><Reference><Citation>Fad&#xf3; R, et al. Novel regulation of the synthesis of &#x3b1;-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (ampa) receptor subunit glua1 by carnitine palmitoyltransferase 1C (CPT1C) in the Hippocampus. J. Biol. Chem. 2015;290:25548&#x2013;25560. doi: 10.1074/jbc.M115.681064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.681064</ArticleId><ArticleId IdType="pmc">PMC4646200</ArticleId><ArticleId IdType="pubmed">26338711</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco P, et al. Ceramide levels regulated by carnitine palmitoyltransferase 1C control dendritic spine maturation and cognition. J. Biol. Chem. 2012;287:21224&#x2013;21232. doi: 10.1074/jbc.M111.337493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.337493</ArticleId><ArticleId IdType="pmc">PMC3375544</ArticleId><ArticleId IdType="pubmed">22539351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1&#x3b1;) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 2011;6:9&#x2013;12. doi: 10.1186/s40035-017-0079-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-017-0079-3</ArticleId><ArticleId IdType="pmc">PMC3156746</ArticleId><ArticleId IdType="pubmed">21771318</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, et al. A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol. Neurodegener. 2011;6:26. doi: 10.1186/1750-1326-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-26</ArticleId><ArticleId IdType="pmc">PMC3111394</ArticleId><ArticleId IdType="pubmed">21521523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. Systemic administration of scAAV9-IGF1 extends survival in SOD1 G93A ALS mice via inhibiting p38 MAPK and the JNK-mediated apoptosis pathway. Brain Res. Bull. 2018;139:203&#x2013;210. doi: 10.1016/j.brainresbull.2018.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.02.015</ArticleId><ArticleId IdType="pubmed">29499331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Garc&#xed;a MJ, Burden SJ. Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep. 2012;2:497&#x2013;502. doi: 10.1016/j.celrep.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.004</ArticleId><ArticleId IdType="pmc">PMC3462266</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza, S. et al. Skeletal-muscle metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target. iScience23, 101087 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, et al. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia. 2019;67:1910&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, et al. Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-&#x3b2;1. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown NF, et al. Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme. J. Lipid Res. 2001;42:1134&#x2013;1142. doi: 10.1016/S0022-2275(20)31604-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)31604-7</ArticleId><ArticleId IdType="pubmed">11441142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, et al. High-resolution metabolomics with acyl-CoA profiling reveals widespread remodeling in response to diet. Mol. Cell. Proteom. 2015;14:1489&#x2013;1500. doi: 10.1074/mcp.M114.044859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M114.044859</ArticleId><ArticleId IdType="pmc">PMC4458715</ArticleId><ArticleId IdType="pubmed">25795660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakimoto PA, Kowaltowski AJ. Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance. Redox Biol. 2016;8:216&#x2013;225. doi: 10.1016/j.redox.2016.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.01.009</ArticleId><ArticleId IdType="pmc">PMC4753394</ArticleId><ArticleId IdType="pubmed">26826574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun HY, Lee T, Jeong Y. High-fat diet increases fat oxidation and promotes skeletal muscle fatty acid transporter expression in exercise-trained mice. J. Med. Food. 2020;23:281&#x2013;288. doi: 10.1089/jmf.2019.4651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2019.4651</ArticleId><ArticleId IdType="pubmed">32119806</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinnankoski-Tuikka R, et al. Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle. Nutr. Metab. 2012;9:1&#x2013;13. doi: 10.1186/1743-7075-9-53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-9-53</ArticleId><ArticleId IdType="pmc">PMC3407034</ArticleId><ArticleId IdType="pubmed">22682013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, et al. High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLoS ONE. 2015;10:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4449222</ArticleId><ArticleId IdType="pubmed">26023930</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieves JW, et al. Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:1425&#x2013;1432. doi: 10.1001/jamaneurol.2016.3401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3401</ArticleId><ArticleId IdType="pmc">PMC5370581</ArticleId><ArticleId IdType="pubmed">27775751</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Grose JH. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. (Paris). 2020 doi: 10.1016/j.neurol.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann. Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip PK, et al. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631166</ArticleId><ArticleId IdType="pubmed">23620776</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly &#xc9;J, et al. Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis. Neurology. 2020;94:e811&#x2013;e819. doi: 10.1212/WNL.0000000000008676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008676</ArticleId><ArticleId IdType="pmc">PMC7136057</ArticleId><ArticleId IdType="pubmed">31796528</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan KS, Halang L, Woods I, Prehn JHM. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice. DMM Dis. Model. Mech. 2016;9:1029&#x2013;1037. doi: 10.1242/dmm.024786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.024786</ArticleId><ArticleId IdType="pmc">PMC5047697</ArticleId><ArticleId IdType="pubmed">27491077</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, et al. Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. J. Nutr. Biochem. 2014;25:885&#x2013;892. doi: 10.1016/j.jnutbio.2014.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2014.04.005</ArticleId><ArticleId IdType="pubmed">24917047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellavance MA, Rivest S. The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain. Front. Immunol. 2014;5:1&#x2013;13. doi: 10.3389/fimmu.2014.00136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00136</ArticleId><ArticleId IdType="pmc">PMC3978367</ArticleId><ArticleId IdType="pubmed">24744759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo T, Harris CA, Wang JC. Metabolic functions of glucocorticoid receptor in skeletal muscle. Mol. Cell. Endocrinol. 2013;380:79&#x2013;88. doi: 10.1016/j.mce.2013.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2013.03.003</ArticleId><ArticleId IdType="pmc">PMC4893778</ArticleId><ArticleId IdType="pubmed">23523565</ArticleId></ArticleIdList></Reference><Reference><Citation>Djurhuus CB, et al. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am. J. Physiol. Endocrinol. Metab. 2002;283:E172&#x2013;E177. doi: 10.1152/ajpendo.00544.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00544.2001</ArticleId><ArticleId IdType="pubmed">12067858</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;nnqvist F, Wennlund A, Wahrenberg H, Arner P. Effects of mental stress on lipolysis in humans. Metabolism. 1992;41:622&#x2013;630. doi: 10.1016/0026-0495(92)90054-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-0495(92)90054-E</ArticleId><ArticleId IdType="pubmed">1322486</ArticleId></ArticleIdList></Reference><Reference><Citation>Divertie GD, Jensen MD, Miles JM. Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes. 1991;40:1228&#x2013;1232. doi: 10.2337/diab.40.10.1228.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.40.10.1228</ArticleId><ArticleId IdType="pubmed">1936585</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, et al. Plasma cortisol level in amyotrophic lateral sclerosis. J. Neurol. Sci. 2015;358:282&#x2013;286. doi: 10.1016/j.jns.2015.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.09.011</ArticleId><ArticleId IdType="pubmed">26384616</ArticleId></ArticleIdList></Reference><Reference><Citation>Roozendaal B, et al. The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood. Psychoneuroendocrinology. 2012;37:20&#x2013;26. doi: 10.1016/j.psyneuen.2011.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2011.04.013</ArticleId><ArticleId IdType="pubmed">21616601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl Acad. Sci. USA. 2012;109:5995&#x2013;5999. doi: 10.1073/pnas.1118355109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1118355109</ArticleId><ArticleId IdType="pmc">PMC3341031</ArticleId><ArticleId IdType="pubmed">22474371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidler JA, et al. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J. 2011;25:4369&#x2013;4377. doi: 10.1096/fj.11-190819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-190819</ArticleId><ArticleId IdType="pmc">PMC3236626</ArticleId><ArticleId IdType="pubmed">21876068</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl Acad. Sci. USA. 2017;114:10719&#x2013;10724. doi: 10.1073/pnas.1711233114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1711233114</ArticleId><ArticleId IdType="pmc">PMC5635914</ArticleId><ArticleId IdType="pubmed">28893994</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vadder F, et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84&#x2013;96. doi: 10.1016/j.cell.2013.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.016</ArticleId><ArticleId IdType="pubmed">24412651</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero, C. et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. DMM Dis. Model. Mech. 13, dmm041947 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 2017;20:145&#x2013;155. doi: 10.1038/nn.4476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4476</ArticleId><ArticleId IdType="pmc">PMC6960010</ArticleId><ArticleId IdType="pubmed">28092661</ArticleId></ArticleIdList></Reference><Reference><Citation>Velagapudi VR, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 2010;51:1101&#x2013;1112. doi: 10.1194/jlr.M002774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M002774</ArticleId><ArticleId IdType="pmc">PMC2853437</ArticleId><ArticleId IdType="pubmed">20040631</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardt, S. &amp; Mohajeri, M. H. Changes of colonic bacterial composition in parkinson&#x2019;s disease and other neurodegenerative diseases. Nutrients10, 708 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6024871</ArticleId><ArticleId IdType="pubmed">29857583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis. Exp. Mol. Med. 50, 21 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5938040</ArticleId><ArticleId IdType="pubmed">29650970</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman SN, Shahi SK, Mangalam AK. The &#x2018;gut feeling&#x2019;: breaking down the role of gut microbiome in multiple sclerosis. Neurotherapeutics. 2018;15:109&#x2013;125. doi: 10.1007/s13311-017-0588-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0588-x</ArticleId><ArticleId IdType="pmc">PMC5794701</ArticleId><ArticleId IdType="pubmed">29204955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Montassier E, Knights D, Wei LN. Gut microbiota from metabolic disease-resistant, macrophage-specific RIP140 knockdown mice improves metabolic phenotype and gastrointestinal integrity. Sci. Rep. 2016;6:1&#x2013;10. doi: 10.1038/s41598-016-0001-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-016-0001-8</ArticleId><ArticleId IdType="pmc">PMC5144013</ArticleId><ArticleId IdType="pubmed">27929078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. High-fat-diet-induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer&#x2019;s patches. Nutrition. 2016;32:265&#x2013;272. doi: 10.1016/j.nut.2015.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2015.08.020</ArticleId><ArticleId IdType="pubmed">26620713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H, Ishaq SL, Zhao FQ, Wright ADG. Colonic inflammation accompanies an increase of &#x3b2;-catenin signaling and Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice. J. Nutr. Biochem. 2016;35:30&#x2013;36. doi: 10.1016/j.jnutbio.2016.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2016.05.015</ArticleId><ArticleId IdType="pubmed">27362974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernberg JN, Bowman CE, Wolfgang MJ, Scafidi S. Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain. J. Neurochem. 2017;142:407&#x2013;419. doi: 10.1111/jnc.14072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14072</ArticleId><ArticleId IdType="pmc">PMC5927624</ArticleId><ArticleId IdType="pubmed">28512781</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecher C, et al. Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat. Neurosci. 2019;22:1731&#x2013;1742. doi: 10.1038/s41593-019-0479-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0479-z</ArticleId><ArticleId IdType="pubmed">31501572</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu CC, Atencio AE, Gallucci S. Inhibition of fatty acid metabolism by etomoxir or TOFA suppresses murine dendritic cell activation without affecting viability. Immunopharmacol. Immunotoxicol. 2019;41:361&#x2013;369. doi: 10.1080/08923973.2019.1616754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2019.1616754</ArticleId><ArticleId IdType="pubmed">31155984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Steyn FJ, Ngo ST, Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target? Cell Biosci. 2021;11:1&#x2013;17. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes ND, et al. Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2- bromopalmitate tracer. J. Lipid Res. 1999;40:1155&#x2013;1169. doi: 10.1016/S0022-2275(20)33520-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)33520-3</ArticleId><ArticleId IdType="pubmed">10357848</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldasoro M, et al. Effects of ranolazine on astrocytes and neurons in primary culture. PLoS ONE. 2016;11:1&#x2013;15. doi: 10.1371/journal.pone.0150619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150619</ArticleId><ArticleId IdType="pmc">PMC4780741</ArticleId><ArticleId IdType="pubmed">26950436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet M, et al. High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice. Neurobiol. Dis. 2012;45:529&#x2013;538. doi: 10.1016/j.nbd.2011.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.09.009</ArticleId><ArticleId IdType="pubmed">21971528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins CPE, et al. Contributions of a high-fat diet to Alzheimer&#x2019;s disease-related decline: a longitudinal behavioural and structural neuroimaging study in mouse models. NeuroImage Clin. 2019;21:101606. doi: 10.1016/j.nicl.2018.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.11.016</ArticleId><ArticleId IdType="pmc">PMC6413478</ArticleId><ArticleId IdType="pubmed">30503215</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol. Rep. 2017;5:1&#x2013;6. doi: 10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13443</ArticleId><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, et al. Effect of chronic corticosterone-induced depression on circadian rhythms and age-related phenotypes in mice. Acta Biochim. Biophys. Sin. (Shanghai). 2018;50:1236&#x2013;1246. doi: 10.1093/abbs/gmy132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmy132</ArticleId><ArticleId IdType="pubmed">30395149</ArticleId></ArticleIdList></Reference><Reference><Citation>Miedel CJ, Patton JM, Miedel AN, Miedel ES, Levenson JM. Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-&#x3b2; and tau neuropathology. J. Vis. Exp. 2017;2017:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608159</ArticleId><ArticleId IdType="pubmed">28605382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>